{"transactions":[{"id":1296469,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83930,"kind":"person","name":"Cao Yang","position":1,"cik":"0001946538","reported_name":"Cao Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-01-23T21:34:47.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":283101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on January 21, 2026, after which 1/48 of the option will become exercisable on the 21st of each month through  January 21, 2029."}],"balance_after":283101,"derivative":{"exercise_price":4.56,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":283101},"source":{"system":"sec-edgar","filing":"0001818382-25-000019","document":"wk-form4_1737668079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838225000019/wk-form4_1737668079.xml","form_type":"4"}},{"id":1714462,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83930,"kind":"person","name":"Cao Yang","position":1,"cik":"0001946538","reported_name":"Cao Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-12-12T21:09:57.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on December 8, 2024, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2027."}],"balance_after":210000,"derivative":{"exercise_price":2.8,"expiration_date":"2033-12-08","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001818382-23-000194","document":"wk-form4_1702415388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838223000194/wk-form4_1702415388.xml","form_type":"4"}},{"id":2154155,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":83930,"kind":"person","name":"Cao Yang","position":1,"cik":"0001946538","reported_name":"Cao Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-09-20T20:09:47.000Z","date":"2022-09-19","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on September 19, 2023, after which 1/48 of the option will become exercisable on the 19th of each month through September 19, 2026."}],"balance_after":145000,"derivative":{"exercise_price":3.73,"expiration_date":"2032-09-19","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001818382-22-000174","document":"wf-form4_166370457260068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838222000174/wf-form4_166370457260068.xml","form_type":"4"}}]}